Orexigen Therapeutics Inc (NASDAQ: OREX) and Bayfield Ventures Corp (TSXV: BYV), lead the top small cap stock gainers for various sectors on both sides of the border, including one that saw its share price surge 33%.
Top U.S. Gainer
|
Company Name |
Exchange |
Ticker |
Market Cap |
Last Price |
Last Volume |
Price Return |
Price Return |
52-Week High |
52-Week Low |
|
Orexigen Therapeutics Inc |
NASDAQ |
OREX |
631.8 |
5.13 |
15,411,849 |
33.2% |
24.5% |
7.82 |
3.11 |
Orexigen Therapeutics Inc (NASDAQ: OREX), engaged in developing drug treatments for obesity and related disorders, was the top performer in the U.S. healthcare sector after gaining 33.2% and closed at $5.13 Monday, while recording significant trading volumes of 15.4 million shares. OREX breached its key technical resistance levels of 30-Day & 50-Day DMAs at $4.03 & $4.48 respectively. Recently, the company announced its financial results for Q3’14 ended September 30, 2014, with OREX reporting net income of $11.3 million, or $0.09 per share, as compared to a net loss of $18.6 million, or $0.19 per share for the Q3’13. During the past 5-trading sessions, OREX gained 24.5% with daily average trading volumes of 4.6 million shares, while the stock accumulated 49.6% gain during the past one month with daily average trading volumes of 3.8 million shares.
1-Year Price Chart
Top Canadian Gainer
|
Company Name |
Exchange |
Ticker |
Market Cap |
Last Price |
Last Volume |
Price Return |
Price Return |
52-Week High |
52-Week Low |
|
Bayfield Ventures Corp |
TSXV |
BYV |
14.7 |
0.19 |
1,162,567 |
32.1% |
32.1% |
0.41 |
0.12 |
Bayfield Ventures Corp (TSXV: BYV), engaged in exploring gold and silver in the Rainy River district of northwestern Ontario was the top sector gainer after climbing 32.1% and closed at C$0.19 Monday, while recording significant trading volumes of 1.1 million shares. BYV broke its key technical resistance levels of 30-Day and 50-Day DMAs at C$0.16 & C$0.17 respectively. Recently, the company announced that it has entered into a definitive arrangement agreement with New Gold Inc. (TSX: NGD), wherein NGD will acquire 100% of the outstanding common shares of BYV at C$0.21 per common share, amounting the deal value to C$16.6 million. According to the terms of the agreement BYV shareholders will receive 0.0477 of a NGD common share for each BYV share held. During the past 5-trading sessions, BYV gained 32.1% with daily average trading volumes of 311,552 shares, while the stock accumulated 8.8% gain during the past one month with daily average trading volumes of 138,956 shares.
1-Year Price Chart
